About Spero Oncology
Spero Oncology is a Healthcare company based in Bellshill (United Kingdom) founded in 2014, and was acquired by Veristat in May 2016. Clinical operations support is provided for oncology trials. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service.
Company details
Spero Oncology was established in 2014 in Bellshill, United Kingdom, as a contract research organization focused on the oncology sector. Clinical operations support is delivered for oncology trials, encompassing feasibility studies, legal representation in the European Union, clinical monitoring, project management, protocol writing, and regulatory strategy. Services are extended primarily across Europe, Australia, and New Zealand. The organization was acquired by U.S.-based CRO Veristat for an undisclosed amount.
- Headquarters Bellshill, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Website spero-oncology.com
- Social LinkedIn X
- Acquired by Veristat (May 2016)
Investors in Spero Oncology
Spero Oncology has secured backing from 1 investor. Prominent investors backing the company include Veristat.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Clinical trials and regulatory submissions are supported as a CRO. | 1994 | veristat.com | Southborough, United States |
Investor details for Spero Oncology
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Spero Oncology
2 dated milestones of Spero Oncology across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Spero Oncology is founded.
- Exit Acquired by Veristat.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Spero Oncology
Spero Oncology was founded in 2014.
Spero Oncology is headquartered in Bellshill, United Kingdom. It is registered at Bellshill, Scotland, United Kingdom.
Spero Oncology was established in 2014 in Bellshill, United Kingdom, as a contract research organization focused on the oncology sector. Clinical operations support is delivered for oncology trials, encompassing feasibility studies, legal representation in the European Union, clinical monitoring, project management, protocol writing, and regulatory strategy. Services are extended primarily across Europe, Australia, and New Zealand. The organization was acquired by U.S.-based CRO Veristat for an undisclosed amount.
Spero Oncology has 1 investor. Key investors include Veristat.
Yes. Spero Oncology was acquired by Veristat in May 2016.